000 | 01068 a2200265 4500 | ||
---|---|---|---|
005 | 20250515085920.0 | ||
264 | 0 | _c20080116 | |
008 | 200801s 0 0 eng d | ||
022 | _a1473-4877 | ||
024 | 7 |
_a10.1185/030079907x233142 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeist, Thomas P | |
245 | 0 | 0 |
_aThe potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation. _h[electronic resource] |
260 |
_bCurrent medical research and opinion _cNov 2007 |
||
300 |
_a2667-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aCladribine _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 | _aTablets |
700 | 1 | _aVermersch, Patrick | |
773 | 0 |
_tCurrent medical research and opinion _gvol. 23 _gno. 11 _gp. 2667-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1185/030079907x233142 _zAvailable from publisher's website |
999 |
_c17405348 _d17405348 |